昭衍新药: insider trades · France · AMF SSE:603127 FR FR · AMF Mcap 24.3Bn€
Discover the full management transaction log of 昭衍新药, a listed issuer based in France. Shares are quoted on FR FR, under the authority of AMF. Market capitalisation: €24.3bn. The latest transaction was disclosed on 30 September 2025 (Sale). Among the most active insiders: 左从林. Every trade is free.
€84,498
43 ops.
Sell Volume
Financial data FY ended December 2025 · cache
Income statement
Revenue 1.66 Bn€
Gross profit 343.3 M€ 21% margin
Net income 297.8 M€ 18.0% margin
Balance sheet & cash
Market cap 24.27 Bn€
Total debt 21.6 M€
Free Cash Flow 301.0 M€
Last declaration on 30 September 2025
Declarations 44 total
Executives ● Sale7 SSE
€84,498 20,000 shares
SSE:173000009615288770 · 30 Sept 2025
Executives ● Sale7 SSE
4,000 shares
SSE:173000007087307460 · 13 Nov 2023
Executives ● Sale7 SSE
3,000 shares
SSE:173000007075373760 · 8 Nov 2023
Executives ● Sale7 SSE
199,960 shares
SSE:173000007068789150 · 6 Nov 2023
Executives ● Sale7 SSE
148,000 shares
SSE:173000007065879970 · 3 Nov 2023
Executives ● Sale7 SSE
489,940 shares
SSE:173000007065879800 · 3 Nov 2023
Executives ● Sale7 SSE
1,000,000 shares
SSE:173000007060665860 · 2 Nov 2023
Executives ● Sale7 SSE
300,000 shares
SSE:173000006685315140 · 27 Jun 2023
Executives ● Sale7 SSE
200,000 shares
SSE:173000006682445340 · 26 Jun 2023
Executives ● Sale7 SSE
300,000 shares
SSE:173000006666870560 · 16 Jun 2023
Executives ● Sale7 SSE
196,300 shares
SSE:173000006654602560 · 12 Jun 2023
Executives ● Sale7 SSE
3,025,954 shares
SSE:173000005913389900 · 27 Sept 2022
Executives ● Sale7 SSE
2,141,980 shares
SSE:173000005894076400 · 6 Sept 2022
Executives ● Sale22 SSE
10,584 shares
SSE:173000005746690560 · 4 Jul 2022
Executives ● Sale7 SSE
2,000 shares
SSE:173000005648954080 · 1 Jul 2022
Executives ● Sale7 SSE
4,775,000 shares
SSE:173000005614953250 · 23 Jun 2022
Executives ● Sale7 SSE
1,000 shares
SSE:173000005599083140 · 16 Jun 2022
Executives ● Sale7 SSE
1,000 shares
SSE:173000005576250560 · 7 Jun 2022
Executives ● Sale7 SSE
320,000 shares
SSE:173000005552153250 · 26 May 2022
Executives ● Sale7 SSE
460,400 shares
SSE:173000005547691360 · 24 May 2022
Executives ● Sale7 SSE
456,370 shares
SSE:173000005545269540 · 23 May 2022
Executives ● Sale7 SSE
286,160 shares
SSE:173000005542844740 · 20 May 2022
Executives ● Sale22 SSE
300,000 shares
SSE:173000005552088300 · 11 May 2022
Executives ● Sale7 SSE
192,700 shares
SSE:173000005176769470 · 16 Dec 2021
Executives ● Sale7 SSE
311,980 shares
SSE:173000004928452030 · 29 Sept 2021
25 of 44 declarations
Load more (19 remaining) About 昭衍新药 Zhaoyan New Drug is a company focused on the research and development of pharmaceuticals. It is listed on the XSHG market.
